Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) and Bureau Veritas Registre International De Classification (OTCMKTS:BVRDF – Get Free Report) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, profitability, risk and earnings.
Risk & Volatility
Pharma-Bio Serv has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, Bureau Veritas Registre International De Classification has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.
Earnings & Valuation
This table compares Pharma-Bio Serv and Bureau Veritas Registre International De Classification”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Pharma-Bio Serv | $9.51 million | 1.45 | -$780,000.00 | ($0.01) | -60.00 |
| Bureau Veritas Registre International De Classification | $6.75 billion | 2.02 | $616.15 million | N/A | N/A |
Bureau Veritas Registre International De Classification has higher revenue and earnings than Pharma-Bio Serv.
Analyst Recommendations
This is a summary of current recommendations for Pharma-Bio Serv and Bureau Veritas Registre International De Classification, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Pharma-Bio Serv | 0 | 0 | 0 | 0 | 0.00 |
| Bureau Veritas Registre International De Classification | 0 | 1 | 0 | 1 | 3.00 |
Profitability
This table compares Pharma-Bio Serv and Bureau Veritas Registre International De Classification’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Pharma-Bio Serv | -0.91% | -0.68% | -0.56% |
| Bureau Veritas Registre International De Classification | N/A | N/A | N/A |
Summary
Bureau Veritas Registre International De Classification beats Pharma-Bio Serv on 9 of the 9 factors compared between the two stocks.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
About Bureau Veritas Registre International De Classification
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Buildings & Infrastructure; Industry; Certification; and Consumer Products. The company engages in inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its clients in relation to regulatory or self-imposed standards, as well as issues compliance reports. It also provides laboratory and on-site testing services for manufacturing and process industries; inspection services for products, services, assets, and installations, as well as various services designed to control quality, verify quantity, and meet regulatory requirements; and certification services for management systems, products, and people. The company serves automotive and transportation, building and infrastructure, chemicals, commodities and agriculture, consumer products and retail, food, marine and offshore, oil and gas, and power and utilities industries, as well as financial services and public sectors. It operates in approximately 140 countries through a network of offices and laboratories. Bureau Veritas SA was founded in 1828 and is headquartered in Neuilly-sur-Seine, France.
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
